Radcliffe Capital Management’s DTRT Health Acquisition Corp. Warrant DTRTW Stock Holding History

Radcliffe Capital Management’s Portfolio DTRTW Stock Details DTRTW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-90,788	Closed	-$941K	–	862
2022 Q4	$941K	Hold	90,788	–	–	0.03%	701
2022 Q3	$922K	Sell	90,788 -5,400	-6%	-$350	0.02%	960
2022 Q2	$968K	Hold	96,188	–	–	0.02%	1004
2022 Q1	$965K	Hold	96,188	–	–	0.02%	996
2021 Q4	$959K	Buy	+96,188	New	+$51K	0.03%	870

Radcliffe Capital Management's DTRTW Position: Q1 2023 in Review

Radcliffe Capital Management sold out of DTRT Health Acquisition Corp. Warrant (DTRTW) in Q1 2023, closing a stake of 90,788 shares — an estimated $941K sold.

Radcliffe Capital Management first reported a position in DTRTW in Q4 2021 and held it in 5 quarters. The position peaked at $968K in Q2 2022. 0 funds tracked by Wall St. Rank hold DTRTW as of Q1 2023.

Radcliffe Capital Management reported no remaining DTRT Health Acquisition Corp. Warrant position as of Q1 2023 after selling out during the quarter.
Radcliffe Capital Management sold 90,788 DTRT Health Acquisition Corp. Warrant shares in Q1 2023, an estimated $941K.
Radcliffe Capital Management first reported a position in DTRT Health Acquisition Corp. Warrant in Q4 2021 and held it in 5 quarters.
Radcliffe Capital Management's DTRT Health Acquisition Corp. Warrant position peaked at $968K in Q2 2022.
0 funds tracked by Wall St. Rank held DTRT Health Acquisition Corp. Warrant as of Q1 2023.

Based on Radcliffe Capital Management's 13F filing for Q1 2023, filed 15 May 2023.